Skip to main content
OpenTrials

Clinical trial condition

Thyroid Diseases

Explore clinical trials studying Thyroid Diseases. Study availability and eligibility vary by location and protocol.

1,049 public trials 244 recruiting studies
Refine in advanced search Browse all conditions

Thyroid Diseases trial results

Active, Not Recruiting

Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer

NCT04624477

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +14 more
Locations
  • University of Calgary, Cumming School of Medicine Calgary, Alberta, Canada
  • University of British Columbia Vancouver, British Columbia, Canada
  • Nova Scotia Health Halifax, Nova Scotia, Canada
  • St. Joseph's Healthcare Hamilton, Ontario, Canada
View Trial Details
Active, Not Recruiting

PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer

NCT04544111

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +22 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

NCT03690388

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +13 more
Locations
  • Exelixis Clinical Site #2 Newport Beach, California, United States
  • Exelixis Clinical Site #98 Sacramento, California, United States
  • Exelixis Clinical Site #69 San Francisco, California, United States
  • Exelixis Clinical Site #10 Stanford, California, United States
View all 164 locations
View Trial Details
Active, Not Recruiting

A Study of LOXO-260 in Cancer Patients With a Change in a Particular Gene (RET) That Has Not Responded to Treatment

NCT05241834

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Emory University Atlanta, Georgia, United States
  • University of Chicago Medicine-Comprehensive Cancer Center Chicago, Illinois, United States
View all 16 locations
View Trial Details

Related conditions